Results 191 to 200 of about 101,867 (267)
Anesthetic implications of psychotropic medications: a narrative review. [PDF]
Jung SM, Park SJ.
europepmc +1 more source
The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents. [PDF]
Steib A +8 more
europepmc +1 more source
2.2Å ブンカイノウ デノ ヒト ユライ モノアミン サンカ コウソA ノ ケッショウ コウゾウ ト ソノ マクカンツウ ヘリックス ノ キノウテキ ヤクワリ [PDF]
Son, Seyoung +2 more
core
Correction to "The MAO-B Inhibitor Selegiline Reduces the Viability of Different Prostate Cancer Cell Lines and Enhances the Effects of Anti-Androgen and Cytostatic Agents". [PDF]
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The therapeutic potential of monoamine oxidase inhibitors
Nature Reviews Neuroscience, 2006Keith F Tipton
exaly +2 more sources
Current Drug Targets, 2021
Monoamine oxidase (MAO) is an enzyme that catalyzes the deamination of monoamines and other proteins. MAO's hyperactivation results in the massive generation of reactive oxygen species, which leads to a variety of neurological diseases such as Alzheimer ...
A. Mannan +5 more
semanticscholar +1 more source
Monoamine oxidase (MAO) is an enzyme that catalyzes the deamination of monoamines and other proteins. MAO's hyperactivation results in the massive generation of reactive oxygen species, which leads to a variety of neurological diseases such as Alzheimer ...
A. Mannan +5 more
semanticscholar +1 more source
An updated patent review on monoamine oxidase (MAO) inhibitors
Expert Opinion on Therapeutic Patents, 2022Introduction Monoamine oxidase (MAO) inhibitors are currently used as antidepressants (selective MAO-A inhibitors) or as co-adjuvants for neurodegenerative diseases (selective MAO-B inhibitors).
Paolo Guglielmi +4 more
semanticscholar +1 more source

